Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adamas Pharmaceuticals
Adamas Pharmaceuticals
(ADMS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Microcrystalline cellulose
lupus nephritis
,
systemic lupus erythematosus
,
nephritis
Potassium magnesium citrate (4:1:2)
lupus nephritis
,
systemic lupus erythematosus
,
nephritis
Fluzone
human influenza
Potassium nitrate
lupus nephritis
,
systemic lupus erythematosus
,
nephritis
Flumist
pneumonia
,
chronic obstructive pulmonary disease
,
pneumococcal pneumonia
,
haemophilus influenzae
,
streptococcus pneumoniae
,
virus diseases
,
respiratory tract diseases
,
respiration disorders
,
arthralgia
,
neisseria meningitidis
,
dengue
,
respiratory syncytial virus infections
,
influenza in birds
,
herpes zoster
,
tetanus
,
diphtheria
,
herpes simplex
,
hepatitis b
,
whooping cough
,
hepatitis
,
poliomyelitis
,
meningococcal infections
,
human influenza
,
h1n1 subtype influenza a virus
,
haemophilus influenzae type b
,
infections
,
common cold
,
healthy volunteers/patients
,
hiv infections
,
otitis media
,
respiratory tract infections
,
communicable diseases
,
disease progression
,
sinusitis
,
asthma
,
bronchitis
,
bronchial spasm
,
multiple sclerosis
,
sclerosis
,
narcolepsy
,
myositis
,
fever
,
infectious encephalitis
,
immunologic tests
,
malaria
,
meningitis
,
pneumococcal infections
,
otitis
,
emergencies
,
drug-related side effects and adverse reactions
Flucelvax
pneumonia
,
chronic obstructive pulmonary disease
,
pneumococcal pneumonia
,
haemophilus influenzae
,
streptococcus pneumoniae
,
virus diseases
,
respiratory tract diseases
,
respiration disorders
,
arthralgia
,
neisseria meningitidis
,
dengue
,
respiratory syncytial virus infections
,
influenza in birds
,
herpes zoster
,
tetanus
,
diphtheria
,
herpes simplex
,
hepatitis b
,
whooping cough
,
hepatitis
,
poliomyelitis
,
meningococcal infections
,
human influenza
,
h1n1 subtype influenza a virus
,
haemophilus influenzae type b
,
infections
,
common cold
,
healthy volunteers/patients
,
hiv infections
,
otitis media
,
respiratory tract infections
,
communicable diseases
,
disease progression
,
sinusitis
,
asthma
,
bronchitis
,
bronchial spasm
,
multiple sclerosis
,
sclerosis
,
narcolepsy
,
myositis
,
fever
,
infectious encephalitis
,
immunologic tests
,
malaria
,
meningitis
,
pneumococcal infections
,
otitis
,
emergencies
,
drug-related side effects and adverse reactions
Isoxaflutole
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use